Form 4 for CUE Cue Biopharma, Inc.
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-15 · accession 0000899243-21-045070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-17 | 2021-11-15+ | CUE | Kiener Peter A | Dir | M - OptEx | $2.86 | +20.2K | 1,361 | New | +$57.7K |
| DM | 2021-11-17 | 2021-11-15+ | CUE | Kiener Peter A | Dir | S - Sale+OE | $17.93 | -20.2K | 0 | -100% | -$361.7K |
| DM | 2021-11-17 | 2021-11-15+ | CUE | Kiener Peter A | Dir | M - OptEx | $0.00 | -20.2K | 105.7K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | M | A | 18,815 | $2.86 | 18,815 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-15 | S | D | 18,815 | $17.92 | 0 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.86 to $18.20, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. |
| 3 | Common | Common Stock | 2021-11-16 | S | D | 1,361 | $18.02 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.86 to $18.31, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4. |
| 4 | Common | Common Stock | 2021-11-16 | M | A | 1,361 | $2.86 | 1,361 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2021-11-15 | M | D | 18,815 | $0.00 | 107,105 | D | $2.86 · — to 2023-03-23 | 18,815 Common Stock | (F4) The option vests in five equal annual installments beginning March 23, 2017. |
| 6 | Derivative | Stock Option (right to buy) | 2021-11-16 | M | D | 1,361 | $0.00 | 105,744 | D | $2.86 · — to 2023-03-23 | 1,361 Common Stock | (F4) The option vests in five equal annual installments beginning March 23, 2017. |